Market Overview

Intra-Cellular Therapies Inc. (NYSE: ITCI)

13.98 +0.36 (2.64%)

Analyst Ratings

DateResearch FirmActionCurrentPT
11/15/18Leerink SwannInitiates Coverage OnOutperform27.0
11/13/18Leerink SwannInitiates Coverage OnOutperform27.0
8/23/18Cantor FitzgeraldInitiates Coverage OnOverweight32.0
2/26/18JP MorganInitiates Coverage OnOverweight25.0
2/08/18RBC CapitalInitiates Coverage OnOutperform33.0
12/15/17Canaccord GenuityInitiates Coverage OnBuy31.0
11/08/17SunTrust Robinson HumphreyUpgradesBuy
8/30/17Ladenburg ThalmannUpgradesBuy
8/24/17JMP SecuritiesUpgradesMarket Outperform
5/02/17Leerink SwannDowngradesMarket Perform

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter